Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500096603Phase 4Completed
Phase 4, randomised, double-blind trial of bendazol in myopia (2 arms), sponsored by Ineye Hospital of Chengdu University of Traditional Chinese Medicine. Primary endpoint: Change from baseline in cycloplegic refraction at Day 186. Started Jan 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500096603.